GSEP
WST icon

Golden State Equity Partners’s West Pharmaceutical WST Stock Holding History

Golden State Equity Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34
Closed -$8.52K – 1759
2026
Q1 		$8.52K Buy
+34
New +$8.46K ﹤0.01% 1349
2024
Q4 		– Sell
-105
Closed -$31.5K – 893
2024
Q3 		$31.5K Sell
105
-1,130
-91% -$346K ﹤0.01% 598
2024
Q2 		$407K Buy
+1,235
New +$436K 0.08% 260

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Golden State Equity Partners's WST Position: Q2 2026 in Review

Golden State Equity Partners sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 34 shares — an estimated $8.52K sold.

Golden State Equity Partners first reported a position in WST in Q2 2024 and held it in 3 quarters. The position peaked at $407K in Q2 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Golden State Equity Partners reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 34 West Pharmaceutical shares in Q2 2026, an estimated $8.52K.
  • Golden State Equity Partners first reported a position in West Pharmaceutical in Q2 2024 and held it in 3 quarters.
  • Golden State Equity Partners's West Pharmaceutical position peaked at $407K in Q2 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.